Tissue differential microarray analysis of dexamethasone induction reveals potential mechanisms of steroid glaucoma

Investigative Ophthalmology and Visual Science

Volumn 44, Issue 2, 2003, Pages 473-485

  Lo, Wayne R ^a   Rowlette, Laura Leigh ^a   Caballero, Montserrat ^a   Yang, Ping ^b   Hernandez, M Rosario ^b   Borrás, Teresa ^a,c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; CORNEA DERIVED TRANSCRIPT 6 PROTEIN; DEXAMETHASONE; MYOCILIN; PIGMENT EPITHELIUM DERIVED FACTOR; PROSTAGLANDIN D2 SYNTHASE; PROSTAGLANDIN SYNTHASE; PROTEIN DERIVATIVE; SERINE PROTEINASE INHIBITOR; STEROID; UNCLASSIFIED DRUG;

ARTICLE; ASTROCYTE; CELL LINE; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOCUS; GENETIC LINKAGE; GLAUCOMA; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PROTEIN INDUCTION; PROTEIN PROCESSING; PROTEIN SECRETION; TRABECULAR MESHWORK; UNINDEXED SEQUENCE;

ASTROCYTES; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL LINE; CYTOSKELETAL PROTEINS; DEXAMETHASONE; ENDOTHELIUM, VASCULAR; EYE PROTEINS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; GLYCOPROTEINS; HELA CELLS; HUMANS; MUSCLE, SKELETAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OPTIC NERVE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRABECULAR MESHWORK; UP-REGULATION;

EID: 0037308624     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.02-0444     Document Type: Article

References (69)

1. Leske MC. The epidemiology of open-angle glaucoma: a review. Am J Epidemiol. 1983;118:166-191.
2. Stone EM, Fingert JH, Alward WLM, et al. Identification of a gene that causes primary open angle glaucoma. Science. 1997;275:668-670.
3. Alward WL, Fingert JH, Coote MA, et al. Clinical features associated with mutations in the chromosome 1 open-angle glaucoma gene (GLC1A). N Engl J Med. 1998;338:1022-1027.
4. Alward WL. The genetics of open-angle glaucoma: the story of GLC1A and myocilin. Eye. 2000;14:429-436.
5. Wordinger RJ, Clark AF. Effects of glucocorticoids on the trabecular meshwork: towards a better understanding of glaucoma. Prog Retin Eye Res. 1999;18:629-667.
6. Polansky JR, Fauss DJ, Chen P, et al. Cellular pharmacology and molecular biology of the trabecular meshwork inducible glucocorticoid response gene product. Ophthalmologica. 1997;211:126-139.
7. Polansky JR. HTM cell culture model for steroid effects on IOP: overview. In: Lütjen-Drecoll E, ed. Basic Aspects of Glaucoma Research III. Stuttgart, Germany: Schattauer; 1993:307-318.
8. Nguyen TD, Chen P, Huang WD, Chen H, Johnson D, Polansky JR. Gene structure and properties of TIGR, an olfactomedin-related glycoprotein cloned from glucocorticoid-induced trabecular meshwork cells. J Biol Chem. 1998;273:6341-6350.
9. Ortego J, Escribano J, Coca-Prados M. Cloning and characterization of subtracted cDNAs from a human ciliary body library encoding TIGR, a protein involved in juvenile open angle glaucoma with homology to myosin and olfactomedin. FEBS Lett. 1997;413:349-353.
10. Kubota R, Noda S, Wang Y, et al. A novel myosin-like protein (myocilin) expressed in the connecting cilium of the photoreceptor: molecular cloning, tissue expression, and chromosomal mapping. Genomics. 1997;41:360-369.
11. Clark AF, Steely HT, Dickerson JE Jr, et al. Glucocorticoid induction of the glaucoma gene MYOC in human and monkey trabecular meshwork cells and tissues. Invest Ophthalmol Vis Sci. 2001;42:1769-1780.
12. Johnson DH. Corticosteroid glaucoma. In: Epstein DL, Allingham RR, Schuman JS, eds. Chandler and Grant's Glaucoma. Baltimore, MD: Williams & Wilkins; 1997:404-411.
13. Craig JE, Snibson GR, Alward WLM. Exclusion of GLC1A coding region mutations as a common cause of steroid-induced ocular hypertension [ARVO Abstract]. Invest Ophthalmol Vis Sci. 1998; 39(4):S687. Abstract nr 3153.
14. Fingert JH, Clark AF, Craig JE, et al. Evaluation of the myocilin (MYOC) glaucoma gene in monkey and human steroid-induced ocular hypertension. Invest Ophthalmol Vis Sci. 2001;42;145-152.
15. Caballero M, Borrás T. Inefficient processing of an olfactomedin-deficient myocilin mutant: potential physiological relevance to glaucoma. Biochem Biophys Res Commun. 2001;282:662-670.
16. Yokoe H, Anholt RR. Molecular cloning of olfactomedin, an extracellular matrix protein specific to olfactory neuroepithelium. Proc Natl Acad Sci USA. 1993;90:4655-4659.
17. Caballero M, Rowlette LL, Borrás T. Altered secretion of a TIGR/MYOC mutant lacking the olfactomedin domain. Biochim Biophys Acta. 2000;1502:447-460.
18. Jacobson N, Andrews M, Shepard AR, et al. Non-secretion of mutant proteins of the glaucoma gene myocilin in cultured trabecular meshwork cells and in aqueous humor. Hum Mol Genet. 2001;10:117-125.
19. Kim BS, Savinova OV, Reedy MV, et al. Targeted disruption of the myocilin gene (Myoc) suggests that human glaucoma-causing mutations are gain of function. Mol Cell Biol. 2001;21:7707-7713.
20. Kirstein L, Cvekl A, Chauhan BK, Tamm ER. Regulation of human myocilin/TIGR gene transcription in trabecular meshwork cells and astrocytes: role of upstream stimulatory factor. Genes Cells. 2000;5:661-676.
21. Fingert JH, Ying L, Swiderski RE, et al. Characterization and comparison of the human and mouse GLC1A glaucoma genes. Genome Res. 1998;8:377-384.
22. Chan GC, Hess P, Meenakshi T, Carlstedt-Duke J, Gustafsson JA, Payvar F. Delayed secondary glucocorticoid response elements. J Biol Chem. 1991;266:22634-22644.
23. Shepard AR, Jacobson N, Fingert JH, Stone EM, Sheffield VC, Clark AF. Delayed secondary glucocorticoid responsiveness of the glaucoma gene myocilin in human trabecular meshwork cells [ARVO Abstract]. Invest Ophthalmol Vis Sci. 2001;42(4):S143. Abstract nr 762.
24. Ricard CS, Agapova OA, Salvador-Silva M, Kaufman PL, Hernandez MR. Expression of myocilin/TIGR in normal and glaucomatous primate optic nerves. Exp Eye Res. 2001;73:433-447.
25. Tanaka Y, Obazawa M, Mashima Y, et al. Cloning and characterization of porcine MYOC in cultured porcine trabecular meshwork cells and astrocytes from optic nerve head. Invest Ophthalmol Vis Sci. 2001;42(4):S830. Abstract nr 4455.
26. Hernandez MR. The optic nerve head in glaucoma: role of astrocytes in tissue remodeling. Prog Retin Eye Res. 2000;19:297-321.
27. Clark AF, Kawase K, English-Wright S, et al. Expression of the glaucoma gene myocilin (MYOC) in the human optic nerve head. FASEB J 2001;1251-1253.
28. Ricard CS, Kobayashi S, Pena JD, Salvador-Silva M, Agapova O, Hernandez MR. Selective expression of neural cell adhesion molecule (NCAM)-180 in optic nerve head astrocytes exposed to elevated hydrostatic pressure in vitro. Brain Res Mol Brain Res. 2000;81:62-79.
29. Vittitow JL, Garg R, Rowlette LL, Epstein DL, O'Brien ET, Borrás T. Gene transfer of dominant-negative RhoA increases outflow facility in perfused human anterior segment cultures. Mol Vis. 2002;8:32-44.
30. Kobayashi S, Vidal I, Pena JD, Hernandez MR. Expression of neural cell adhesion molecule (NCAM) characterizes a subpopulation of type 1 astrocytes in human optic nerve head. Glia. 1997;20:262-273.
31. Salvador-Silva M, Ricard CS, Agapova OA, Yang P, Hernandez MR. Expression of small heat shock proteins and intermediate filaments in the human optic nerve head astrocytes exposed to elevated hydrostatic pressure in vitro. J Neurosci Res. 2001;66:59-73.
32. Mi H, Barres BA. Purification and characterization of astrocyte precursor cells in the developing rat optic nerve. J Neurosci. 1999;19:1049-1061.
33. Barbu V, Dautry F. Northern blot normalization with a 28S rRNA oligonucleotide probe. Nucleic Acids Res. 1989;17:7115.
34. Adam MF, Belmouden A, Binisti P, et al. Recurrent mutations in a single exon encoding the evolutionarily conserved olfactomedin-homology domain of TIGR in familial open-angle glaucoma. Hum Mol Genet. 1997;6:2091-2097.
35. Stamer WD, Roberts BC, Howell DN, Epstein DL. Isolation, culture, and characterization of endothelial cells from Schlemm's canal. Invest Ophthalmol Vis Sci. 1998;39:1804-1812.
36. Borrás T, Rowlette LL, Tamm ER, Gottanka J, Epstein DL. Effects of elevated intraocular pressure on outflow facility and TIGR/MYOC expression in perfused human anterior segments. Invest Ophthalmol Vis Sci. 2002;43:33-40.
37. Abraham CR, Shirahama T, Potter H. Alpha 1-antichymotrypsin is associated solely with amyloid deposits containing the beta-protein: amyloid and cell localization of alpha 1-antichymotrypsin. Neurobiol Aging. 1990;11:123-129.
38. Taniwaki T, Hirashima N, Becerra SP, Chader GJ, Etcheberrigaray R, Schwartz JP. Pigment epithelium-derived factor protects cultured cerebellar granule cells against glutamate-induced neurotoxicity. J Neurochem. 1997;68:26-32.
39. Kessler E, Mould AP, Hulmes DJ. Procollagen type I C-proteinase enhancer is a naturally occurring connective tissue glycoprotein. Biochem Biophys Res Commun. 1990;173:81-86.
40. Hakala BE, White C, Recklies AD. Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family. J Biol Chem. 1993;268:25803-25810.
41. Peek R, Kammerer RA, Frank S, Otte-Holler I, Westphal JR. The angiopoietin-like factor cornea-derived transcript 6 is a putative morphogen for human cornea. J Biol Chem. 2002;277:686-693.
42. Urade Y, Hayaishi O. Prostaglandin D synthase: structure and function. Vitam Horm. 2000;58:89-120.
43. Matsuura K, Shiraishi H, Hara A, et al. Identification of a principal mRNA species for human 3alpha-hydroxysteroid dehydrogenase isoform (AKR1C3) that exhibits high prostaglandin D2 11-ketore-ductase activity. J Biochem (Tokyo). 1998;124:940-946.
44. Reindl M, Knipping G, Wicher I, et al. Increased intrathecal production of apolipoprotein D in multiple sclerosis. J Neuroimmunol. 2001;119:327-332.
45. Thomas EA, Dean B, Pavey G, Sutcliffe JG. Increased CNS levels of apolipoprotein D in schizophrenic and bipolar subjects: implications for the pathophysiology of psychiatric disorders. Proc Natl Acad Sci USA. 2001;98:4066-4071.
46. Carmel JB, Galante A, Soteropoulos P, et al. Gene expression profiling of acute spinal cord injury reveals spreading inflammatory signals and neuron loss. Physiol Genomics. 2001;7:201-213.
47. Acott TS. Trabecular extracellular matrix regulation. In: Drance SM, Van Buskirk EM, Neufeld AH, eds. Pharmacology of Glaucoma. Baltimore: Williams & Wilkins; 1992:125-157.
48. Alexander JP, Samples JR, Van Buskirk EM, Acott TS. Expression of matrix metalloproteinases and inhibitor by human trabecular meshwork. Invest Ophthalmol Vis Sci. 1991;32:172-180.
49. Abraham CR, Selkoe DJ, Potter H, Price DL, Cork LC. Alpha 1-antichymotrypsin is present together with the beta-protein in monkey brain amyloid deposits. Neuroscience. 1989;32:715-720.
50. Shoji M, Hirai S, Yamaguchi H, Harigaya Y, Ishiguro K, Matsubara E. Alpha 1-antichymotrypsin is present in diffuse senile plaques. A comparative study of beta-protein and alpha 1-antichymotrypsin immunostaining in the Alzheimer brain. Am J Pathol. 1991;138:247-257.
51. Johnson D, Gottanka J, Flugel C, Hoffmann F, Futa R, Lütjen-Drecoll E. Ultrastructural changes in the trabecular meshwork of human eyes treated with corticosteroids. Arch Ophthalmol. 1997; 115:375-383.
52. Clark AF, Wilson K, de Kater AW, Allingham RR, McCartney MD. Dexamethasone-induced ocular hypertension in perfusion-cultured human eyes. Invest Ophthalmol Vis Sci. 1995;36:478-489.
53. Stoilov I, Akarsu AN, Sarfarazi M. Identification of three different truncating mutations in cytochrome P4501B1 (CYP1B1) as the principal cause of primary congenital glaucoma (Buphthalmos) in families linked to the GLC3A locus on chromosome 2p21. Hum Mol Genet. 1997;6:641-647.
54. Gonzalez P, Epstein DL, Borrás T. Characterization of gene expression in human trabecular meshwork using single-pass sequencing of 1060 clones. Invest Ophthalmol Vis Sci. 2000;41:3678-3693.
55. Araki T, Taniwaki T, Becerra SP, Chader GJ, Schwartz JP. Pigment epithelium-derived factor (PEDF) differentially protects immature but not mature cerebellar granule cells against apoptotic cell death. J Neurosci Res. 1998;53:7-15.
56. Cao W, Tombran-Tink J, Elias R, Sezate S, Mrazek D, McGinnis JF. In vivo protection of photoreceptors from light damage by pigment epithelium-derived factor. Invest Ophthalmol Vis Sci. 2001; 42:1646-1652.
57. Toris CB, Camras CB, Yablonski ME, Brubaker RF. Effects of exogenous prostaglandins on aqueous humor dynamics and blood-aqueous barrier function. Surv Ophthalmol. 1997;41(suppl 2): S69-S75.
58. Gerashchenko DY, Beuckmann CT, Marcheselli VL, et al. Localization of lipocalin-type prostaglandin D synthase (beta-trace) in iris, ciliary body, and eye fluids. Invest Ophthalmol Vis Sci. 1998;39:198-203.
59. Hernandez MR, Agapova OA, Yang P, Salvador-Silva M, Ricard CS, Aoi S. Differential gene expression in astrocytes from human normal and glaucomatous optic nerve head analyzed by cDNA microarray. Glia. 2002;38:45-64.
60. Penning TM, Burczynski ME, Jez JM, et al. Structure-function aspects and inhibitor design of type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3). Mol Cell Endocrinol. 2001;171:137-149.
61. Weinstein BI, Munnangi P, Gordon GG, Southren AL. Defects in cortisol-metabolizing enzymes in primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 1985;26:890-893.
62. Southren AL, Wandel T, Gordon GG, Weinstein BI. Treatment of glaucoma with 3 alpha, 5 beta-tetrahydrocortisol: a new therapeutic modality. J Ocul Pharmacol. 1994;10:385-391.
63. Southren AL, l'Hommedieu D, Gordon GG, Weinstein BI. Intraocular hypotensive effect of a topically applied cortisol metabolite: 3 alpha, 5 beta-tetrahydrocortisol. Invest Ophthalmol Vis Sci. 1987; 28:901-903.
64. Southren AL, Gordon GG, l'Hommedieu D, Ravikumar S, Dunn MW, Weinstein BI. 5 beta-Dihydrocortisol: possible mediator of the ocular hypertension in glaucoma. Invest Ophthalmol Vis Sci. 1985;26:393-395.
65. Yun AJ, Murphy CG, Polansky JR, Newsome DA, Alvarado JA. Proteins secreted by human trabecular cells: glucocorticoid and other effects. Invest Ophthalmol Vis Sci. 1989;30:2012-2022.
66. Pena JD, Roy S, Hernandez MR. Tropoelastin gene expression in optic nerve heads of normal and glaucomatous subjects. Matrix Biol. 1996;15:323-330.
67. Kahari VM. Dexamethasone suppresses elastin gene expression in human skin fibroblasts in culture. Biochem Biophys Res Commun. 1994;201:1189-1196.
68. Del Monaco M, Covello SP, Kennedy SH, Gilinger G, Litwack G, Uitto J. Identification of novel glucocorticoid-response elements in human elastin promoter and demonstration of nucleotide sequence specificity of the receptor binding. J Invest Dermatol. 1997;108:938-942.
69. Ledo I, Wu M, Katchman S, Brown D, Kennedy S, Hsu-Wong S, Uitto J. Glucocorticosteroids upregulate human elastin gene promoter activity in transgenic mice. J Invest Dermatol. 1994;103:632-636.